Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Neuromuscul Disord ; 31(5): 462-465, 2021 05.
Article in English | MEDLINE | ID: mdl-33741226

ABSTRACT

Duchenne muscular dystrophy is an X-Linked neuromuscular disorder, and the most common muscular dystrophy. Neuropsychiatric phenotype associated to DMD gene mutations include now low IQ scores, epilepsy, autism, and attention deficit disorder. These have been observed with higher frequency in mutations that disrupt the short isoforms Dp71 and Dp140. West syndrome has been previously reported in two unrelated patients with Duchenne muscular dystrophy. Here, we report the third patient with West syndrome who had a novel hemizygous nonsense pathogenic variant in the exon 8 of the DMD gene c.811C>T, p.(Gln271*), suggesting West syndrome as part of the neuropsychiatric spectrum in Duchenne muscular dystrophy.


Subject(s)
Muscular Dystrophy, Duchenne/genetics , Phenotype , Spasms, Infantile/genetics , Dystrophin/genetics , Epilepsy/genetics , Exons , Humans , Infant , Intellectual Disability/genetics , Male , Mutation , Protein Isoforms/genetics
2.
Immunol Lett ; 163(2): 221-6, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25447399

ABSTRACT

Psoriasis is a chronic autoimmune inflammatory disease that affects the skin and the joints. Psoriasis is characterized by the keratinocyte proliferation, which is induced by cytokines Th1 and Th17. Patients with plaque psoriasis present a chronic inflammatory response with high levels of interleukin (IL)-12 and IL-23. Various single-nucleotide polymorphisms (SNP) have been identified in the IL12B gene, such as SNP 3' UTR 1188 A/C (SNP rs3212227), which has been associated with susceptibility to developing plaque psoriasis and with the production of IL-12 and IL-23 in individuals of different ethnic groups. In this study, we determined whether there is an association of SNP rs3212227 with the susceptibility of developing plaque psoriasis and with serum levels of IL-12 and IL-23 in Mestizo population in western Mexico. We included 112 patients with psoriasis and 112 clinical healthy individuals in the study. The frequencies of genotypes A/A, A/C, and C/C in patients with plaque psoriasis were 41, 53, and 6%, respectively, while in the control group, these were 37, 53, and 10%, respectively, without finding statistically significant differences between both groups (p>0.05). Although IL-12 and IL-23 serum levels were higher in patients than in controls, we found no significant differences. The group of patients with genotype CC presented the highest levels of IL-23 (p<0.05). These data suggest that the SNP rs3212227 phenotype is not associated with the risk of developing plaque psoriasis or with IL-12 and IL-23 levels in Mestizo population in western Mexico.


Subject(s)
3' Untranslated Regions/genetics , Ethnicity/genetics , Genetic Predisposition to Disease/genetics , Interleukin-12 Subunit p40/genetics , Polymorphism, Single Nucleotide , Psoriasis/genetics , Adult , Alleles , Analysis of Variance , Case-Control Studies , Female , Gene Frequency , Genotype , Humans , Interleukin-12/blood , Interleukin-23/blood , Male , Mexico , Middle Aged , Odds Ratio , Psoriasis/blood , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL